Effects of cis-diamminedichloroplatinum (NSC-119875) on hearing function in man.
D000293:Adolescent; D000328:Adult; D001299:Audiometry; D001772:Blood Cell Count; D001792:Blood Platelets; D002945:Cisplatin / Q000009:adverse effects* / Q000627:therapeutic use; D003404:Creatinine / Q000097:blood; D004305:Dose-Response Relationship, Drug; D005260:Female; D006311:Hearing Disorders / Q000139:chemically induced* / Q000175:diagnosis; D006452:Hemoglobinometry; D006801:Humans; D007958:Leukocyte Count; D008297:Male; D008875:Middle Aged; D009369:Neoplasms / Q000188:drug therapy; D014527:Uric Acid / Q000097:blood
D014527:Uric Acid; D003404:Creatinine; D002945:Cisplatin